miR-145 contributes to hypertrophic scarring of the skin by inducing myofibroblast activity

Molecular Medicine

Volumn 21, Issue , 2015, Pages 296-304

  Gras, Christiane ^a   Ratuszny, Dominica ^a   Hadamitzky, Catarina ^a   Zhang, Haijiao ^a   Blasczyk, Rainer ^a   Figueiredo, Constança ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DERMATOLOGICAL AGENT; KRUPPEL LIKE FACTOR 4; MICRORNA 145; MICRORNA 145 INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ACTA2 PROTEIN, HUMAN; ACTIN; KRUPPEL LIKE FACTOR; MICRORNA; MIRN145 MICRORNA, HUMAN;

ARTICLE; CELL CONTRACTION ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; IN VITRO STUDY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RNA GENE; SCAR FORMATION; SKIN FIBROBLAST; SKIN FIBROSIS; TARGET CELL; UPREGULATION; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; RNA INTERFERENCE;

ACTINS; CELL DIFFERENTIATION; CELL MOVEMENT; CICATRIX, HYPERTROPHIC; COLLAGEN TYPE I; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICRORNAS; MYOFIBROBLASTS; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84937545824     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2014.00172     Document Type: Article

References (28)

1. Kathju S, Gallo PH, Satish L. (2012) Scarless integumentary wound healing in the mammalian fetus: molecular basis and therapeutic implications. Birth Defects Res. C. Embryo Today. 96:223-36.
2. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A. (2008) The hidden cost of skin scars: quality of life after skin scarring. J. Plast. Reconstr. Aesthet. Surg. 61:1049-58.
3. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. (2002) Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat. Rev. Mol. Cell. Biol. 3:349-63.
4. Liu J, et al. (2012) Wnt/beta-catenin pathway forms a negative feedback loop during TGF-beta1 induced human normal skin fibroblast-to-myofibroblast transition. J. Dermatol. Sci. 65:38-49.
5. Hinz B, et al. (2012) Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 180:1340-55.
6. Brown BD, Naldini L. (2009) Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 10:578-85.
7. Thomas M, Lieberman J, Lal A. (2010) Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 17:1169-74.
8. Lanford RE, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327:198-201.
9. Thum T, et al. (2011) Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J. Clin. Invest. 121:461-462; author reply 462-463.
10. Cheng J, Wang Y, Wang D, Wu Y. (2012) Identification of collagen 1 as a post-transcriptional target of miR-29b in skin fibroblasts: therapeutic implication for scar reduction. Am. J. Med. Sci. 346:98-103.
11. Kashiyama K, et al. (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J. Invest. Dermatol. 132:1597-604.
12. Gras C, et al. (2013) HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model. Hum. Gene Ther. 24:1018-28.
13. Mia MM, Boersema M, Bank RA. (2014) Interleukin-1beta attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-beta1. PLoS One. 9:e91559.
14. Pan Z, et al. (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation. 126:840-50.
15. Robinson PM, et al. (2013) MicroRNA signature in wound healing following excimer laser ablation: role of miR-133b on TGFbeta1, CTGF, SMA, and COL1A1 expression levels in rabbit corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 54:6944-51.
16. Yang S, et al. (2013) miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 27:2382-91.
17. Wang YS, et al. (2013) Role of miR-145 in cardiac myofibroblast differentiation. J. Mol. Cell Cardiol. 66:94-105.
18. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 137:647-58.
19. Davis-Dusenbery BN, et al. (2011) Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J. Biol. Chem. 286:28097-110.
20. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. (2007) Myofibroblast contraction activates latent TGFbeta1 from the extracellular matrix. J. Cell Biol. 179:1311-23.
21. Gurtner GC, Werner S, Barrandon Y, Longaker MT. (2008) Wound repair and regeneration. Nature. 453:314-21.
22. Penn JW, Grobbelaar AO, Rolfe KJ. (2012) The role of the TGF-beta family in wound healing, burns and scarring: a review. Int. J. Burns Trauma. 2:18-28.
23. Cheng J, Yu H, Deng S, Shen G. (2010) MicroRNA profiling in mid-and late-gestational fetal skin: implication for scarless wound healing. Tohoku J. Exp. Med. 221:203-9.
24. Li C, et al. (2013) Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs. Acta Biochim. Biophys. Sin. (Shanghai). 45:692-699.
25. Chang HY, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 99:12877-82.
26. Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY. (2006) Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet. 2:e119.
27. Wang R, et al. (2000) Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen. 8:128-37.
28. Zhao R, Yan Q, Huang H, Lv J, Ma W. (2013) Transdermal siRNA-TGFbeta1-337 patch for hypertrophic scar treatment. Matrix Biol. 32:265-76.